Additionally, the high BUB1 expression subtype predicted shorter survival than the low expression subtype, consistent with the study of ovarian cancer [36], gastric cancer [38], and pancreatic ductal adenocarcinoma [11]. Here, BUB1 is linked to pancreatic ductal adenocarcinoma.